Johnson & Johnson (NYSE:JNJ) announced today that it received FDA approval for its dual-energy ThermoCool SmartTouch SF platform (DE STSF).
Each year, thousands of patients in the United States wait for a liver transplant, while transplant teams must make rapid, difficult decisions about whether donor organs are suitable for use.
Stem cell transplantation (also called bone marrow transplantation) and gene therapy are among the most powerful curative approaches for blood diseases such as sickle cell disease, b-thalassemia, immune deficiencies and some blood cancers.
FDA-cleared camera-based vital signs platform offers heart rate and breathing rate at no cost to hospitals, clinics, health organizations, and educators.
Vera Therapeutics’ atacicept, to be marketed as Trutakna, will go up against Novartis, Otsuka and possibly Vertex in the kidney disease primary IgA nephropathy after receiving an accelerated FDA approval.
Beckman Coulter’s assay is used to measure phosphorylated tau (pTau217) levels in the blood of individuals displaying signs of cognitive decline.
Japanese medtech company Medicaroid announced today that it received CE mark approval for its Hinotori surgical robot system.
A University of Texas at Austin-led team of researchers has developed a noninvasive patch that boosts REM sleep in real-world trials without surgery or medication.
WILMINGTON, Del., July 6, 2026 /PRNewswire/ — Reprotech today announced that the TMRW Vault® has received CE marking as a Class IIa medical device under Regulation (EU) 2017/745, supporting commercialization in the European Union and other international markets that recognize the CE mark.
xDot Medical announced today that it received FDA investigational device exemption (IDE) approval for its access management system (AMS).